NYSE:USNAPersonal Products
USANA Health Sciences (USNA) Margin Compression To 1.2% Tests Bullish Earnings Narratives
USANA Health Sciences (USNA) closed FY 2025 with Q4 revenue of US$226.2 million and a basic EPS loss of US$0.10, as net income excluding extra items came in at a loss of US$1.8 million. Over the last six reported quarters, revenue has moved between US$200.2 million and US$249.5 million, while quarterly basic EPS has ranged from a profit of US$0.56 to a loss of US$0.36, and trailing twelve month EPS stood at US$0.58 on revenue of US$925.3 million in Q4 2025. For investors, the key story this...